abstract |
Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR40 receptor. Such compounds are represented by Formula (I) as follows: n nwherein R 1 , R 2 , R 3 , R 5 , R 6 , W, and A are defined herein. |